Molecular virology of hepatitis C

Hepatitis C virus (HCV) infection is a leading cause of chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma worldwide. Here, we will briefly review current concepts of the molecular virology of hepatitis C. In vitro and in vivo models of HCV replication will be discussed in this context...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Praxis (Bern. 1994) 2002-12, Vol.91 (51-52), p.2247-2253
Hauptverfasser: Moradpour, D, Brass, V, Gosert, R, Wölk, B, Blum, H E
Format: Artikel
Sprache:ger
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 2253
container_issue 51-52
container_start_page 2247
container_title Praxis (Bern. 1994)
container_volume 91
creator Moradpour, D
Brass, V
Gosert, R
Wölk, B
Blum, H E
description Hepatitis C virus (HCV) infection is a leading cause of chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma worldwide. Here, we will briefly review current concepts of the molecular virology of hepatitis C. In vitro and in vivo models of HCV replication will be discussed in this context. Finally, novel antiviral strategies will be outlined that result from an improved understanding of the viral life cycle.
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_72839988</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>72839988</sourcerecordid><originalsourceid>FETCH-LOGICAL-p541-c731dc8a18545e5ead8f3f681f0f31540215c653691127d2f720540c763da3b93</originalsourceid><addsrcrecordid>eNo1j81KxDAYRbNQnHH0FaRu3BXyJfmSdCnFPxhxM_uSyY9GUlOTVpi3d8BxdeByuHDOyBqkhFYDqhW5rPWTUik6hhdkBQyloALW5PY1J2-XZErzE0tO-f3Q5NB8-MnMcY616a_IeTCp-usTN2T3-LDrn9vt29NLf79tJxTQWsXBWW1Ao0CP3jgdeJAaAg0cUFAGaCVy2QEw5VhQjB5XqyR3hu87viF3f7dTyd-Lr_Mwxmp9SubL56UOimnedVofxZuTuOxH74apxNGUw_DfxH8BvnZEew</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>72839988</pqid></control><display><type>article</type><title>Molecular virology of hepatitis C</title><source>Hogrefe eContent</source><source>MEDLINE</source><creator>Moradpour, D ; Brass, V ; Gosert, R ; Wölk, B ; Blum, H E</creator><creatorcontrib>Moradpour, D ; Brass, V ; Gosert, R ; Wölk, B ; Blum, H E</creatorcontrib><description>Hepatitis C virus (HCV) infection is a leading cause of chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma worldwide. Here, we will briefly review current concepts of the molecular virology of hepatitis C. In vitro and in vivo models of HCV replication will be discussed in this context. Finally, novel antiviral strategies will be outlined that result from an improved understanding of the viral life cycle.</description><identifier>ISSN: 1661-8157</identifier><identifier>PMID: 12564041</identifier><language>ger</language><publisher>Switzerland</publisher><subject>Animals ; Antiviral Agents - therapeutic use ; Cells, Cultured ; Disease Models, Animal ; Enzyme Inhibitors - therapeutic use ; Forecasting ; Genes, Viral ; Genetic Therapy ; Hepacivirus - enzymology ; Hepacivirus - genetics ; Hepacivirus - physiology ; Hepatitis C - complications ; Hepatitis C - drug therapy ; Hepatitis C - therapy ; Hepatitis C - virology ; Hepatocytes - virology ; Humans ; Mice ; Mice, Transgenic ; Pan troglodytes ; Polyproteins - genetics ; Polyproteins - metabolism ; Protease Inhibitors - therapeutic use ; Protein Biosynthesis ; Replicon - genetics ; RNA, Viral - genetics ; Transcription, Genetic ; Tumor Cells, Cultured ; Tupaia ; Viral Proteins - genetics ; Viral Proteins - metabolism ; Virus Replication</subject><ispartof>Praxis (Bern. 1994), 2002-12, Vol.91 (51-52), p.2247-2253</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12564041$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Moradpour, D</creatorcontrib><creatorcontrib>Brass, V</creatorcontrib><creatorcontrib>Gosert, R</creatorcontrib><creatorcontrib>Wölk, B</creatorcontrib><creatorcontrib>Blum, H E</creatorcontrib><title>Molecular virology of hepatitis C</title><title>Praxis (Bern. 1994)</title><addtitle>Praxis (Bern 1994)</addtitle><description>Hepatitis C virus (HCV) infection is a leading cause of chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma worldwide. Here, we will briefly review current concepts of the molecular virology of hepatitis C. In vitro and in vivo models of HCV replication will be discussed in this context. Finally, novel antiviral strategies will be outlined that result from an improved understanding of the viral life cycle.</description><subject>Animals</subject><subject>Antiviral Agents - therapeutic use</subject><subject>Cells, Cultured</subject><subject>Disease Models, Animal</subject><subject>Enzyme Inhibitors - therapeutic use</subject><subject>Forecasting</subject><subject>Genes, Viral</subject><subject>Genetic Therapy</subject><subject>Hepacivirus - enzymology</subject><subject>Hepacivirus - genetics</subject><subject>Hepacivirus - physiology</subject><subject>Hepatitis C - complications</subject><subject>Hepatitis C - drug therapy</subject><subject>Hepatitis C - therapy</subject><subject>Hepatitis C - virology</subject><subject>Hepatocytes - virology</subject><subject>Humans</subject><subject>Mice</subject><subject>Mice, Transgenic</subject><subject>Pan troglodytes</subject><subject>Polyproteins - genetics</subject><subject>Polyproteins - metabolism</subject><subject>Protease Inhibitors - therapeutic use</subject><subject>Protein Biosynthesis</subject><subject>Replicon - genetics</subject><subject>RNA, Viral - genetics</subject><subject>Transcription, Genetic</subject><subject>Tumor Cells, Cultured</subject><subject>Tupaia</subject><subject>Viral Proteins - genetics</subject><subject>Viral Proteins - metabolism</subject><subject>Virus Replication</subject><issn>1661-8157</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo1j81KxDAYRbNQnHH0FaRu3BXyJfmSdCnFPxhxM_uSyY9GUlOTVpi3d8BxdeByuHDOyBqkhFYDqhW5rPWTUik6hhdkBQyloALW5PY1J2-XZErzE0tO-f3Q5NB8-MnMcY616a_IeTCp-usTN2T3-LDrn9vt29NLf79tJxTQWsXBWW1Ao0CP3jgdeJAaAg0cUFAGaCVy2QEw5VhQjB5XqyR3hu87viF3f7dTyd-Lr_Mwxmp9SubL56UOimnedVofxZuTuOxH74apxNGUw_DfxH8BvnZEew</recordid><startdate>20021218</startdate><enddate>20021218</enddate><creator>Moradpour, D</creator><creator>Brass, V</creator><creator>Gosert, R</creator><creator>Wölk, B</creator><creator>Blum, H E</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>20021218</creationdate><title>Molecular virology of hepatitis C</title><author>Moradpour, D ; Brass, V ; Gosert, R ; Wölk, B ; Blum, H E</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p541-c731dc8a18545e5ead8f3f681f0f31540215c653691127d2f720540c763da3b93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>ger</language><creationdate>2002</creationdate><topic>Animals</topic><topic>Antiviral Agents - therapeutic use</topic><topic>Cells, Cultured</topic><topic>Disease Models, Animal</topic><topic>Enzyme Inhibitors - therapeutic use</topic><topic>Forecasting</topic><topic>Genes, Viral</topic><topic>Genetic Therapy</topic><topic>Hepacivirus - enzymology</topic><topic>Hepacivirus - genetics</topic><topic>Hepacivirus - physiology</topic><topic>Hepatitis C - complications</topic><topic>Hepatitis C - drug therapy</topic><topic>Hepatitis C - therapy</topic><topic>Hepatitis C - virology</topic><topic>Hepatocytes - virology</topic><topic>Humans</topic><topic>Mice</topic><topic>Mice, Transgenic</topic><topic>Pan troglodytes</topic><topic>Polyproteins - genetics</topic><topic>Polyproteins - metabolism</topic><topic>Protease Inhibitors - therapeutic use</topic><topic>Protein Biosynthesis</topic><topic>Replicon - genetics</topic><topic>RNA, Viral - genetics</topic><topic>Transcription, Genetic</topic><topic>Tumor Cells, Cultured</topic><topic>Tupaia</topic><topic>Viral Proteins - genetics</topic><topic>Viral Proteins - metabolism</topic><topic>Virus Replication</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Moradpour, D</creatorcontrib><creatorcontrib>Brass, V</creatorcontrib><creatorcontrib>Gosert, R</creatorcontrib><creatorcontrib>Wölk, B</creatorcontrib><creatorcontrib>Blum, H E</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Praxis (Bern. 1994)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Moradpour, D</au><au>Brass, V</au><au>Gosert, R</au><au>Wölk, B</au><au>Blum, H E</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Molecular virology of hepatitis C</atitle><jtitle>Praxis (Bern. 1994)</jtitle><addtitle>Praxis (Bern 1994)</addtitle><date>2002-12-18</date><risdate>2002</risdate><volume>91</volume><issue>51-52</issue><spage>2247</spage><epage>2253</epage><pages>2247-2253</pages><issn>1661-8157</issn><abstract>Hepatitis C virus (HCV) infection is a leading cause of chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma worldwide. Here, we will briefly review current concepts of the molecular virology of hepatitis C. In vitro and in vivo models of HCV replication will be discussed in this context. Finally, novel antiviral strategies will be outlined that result from an improved understanding of the viral life cycle.</abstract><cop>Switzerland</cop><pmid>12564041</pmid><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1661-8157
ispartof Praxis (Bern. 1994), 2002-12, Vol.91 (51-52), p.2247-2253
issn 1661-8157
language ger
recordid cdi_proquest_miscellaneous_72839988
source Hogrefe eContent; MEDLINE
subjects Animals
Antiviral Agents - therapeutic use
Cells, Cultured
Disease Models, Animal
Enzyme Inhibitors - therapeutic use
Forecasting
Genes, Viral
Genetic Therapy
Hepacivirus - enzymology
Hepacivirus - genetics
Hepacivirus - physiology
Hepatitis C - complications
Hepatitis C - drug therapy
Hepatitis C - therapy
Hepatitis C - virology
Hepatocytes - virology
Humans
Mice
Mice, Transgenic
Pan troglodytes
Polyproteins - genetics
Polyproteins - metabolism
Protease Inhibitors - therapeutic use
Protein Biosynthesis
Replicon - genetics
RNA, Viral - genetics
Transcription, Genetic
Tumor Cells, Cultured
Tupaia
Viral Proteins - genetics
Viral Proteins - metabolism
Virus Replication
title Molecular virology of hepatitis C
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T10%3A23%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Molecular%20virology%20of%20hepatitis%20C&rft.jtitle=Praxis%20(Bern.%201994)&rft.au=Moradpour,%20D&rft.date=2002-12-18&rft.volume=91&rft.issue=51-52&rft.spage=2247&rft.epage=2253&rft.pages=2247-2253&rft.issn=1661-8157&rft_id=info:doi/&rft_dat=%3Cproquest_pubme%3E72839988%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=72839988&rft_id=info:pmid/12564041&rfr_iscdi=true